[1] Miyazaki M,Tsumura H,Wang JC,et al.An update on bone substitutes for spinal fusion.Eur Spine J.2009;18(6):783-799.
[2] Bueno EM, Glowacki J.Cell-free and cell-based approaches for bone regeneration. Nat Rev Rheumatol. 2009;5(12): 685-697.
[3] Kimelman N,Pelled G,Helm GA,et al.Review: Gene- and cell-based therapeutics for bone regeneration and repair. Tissue Eng.2007;13(6):1135-1150.
[4] Awad HA,Zhang X,Reynolds DG,et al.Recent advances in gene delivery for structural bone allografts.Tissue Eng.2007; 13(8):1973-1985.
[5] LeGeros RZ. Properties of osteoconductive biomaterials: calcium phosphates. Clin Orthop.2002;1:81-98.
[6] Zhang Z,Mao J,Feng X,et al.In vitro cytotoxicity of polyphosphoester as a novel injectable alveolar replacement material. J Huazhong Univ Sci Technolog Med Sci.2008; 28(5):604-607.
[7] Hesaraki S,Zamanian A,Moztarzadeh F.The influence of the acidic component of the gas-foaming porogen used in preparing an injectable porous calcium phosphate cement on its properties: acetic acid versus citric acid. J Biomed Mater Res B Appl Biomater.2008;86(1):208-216.
[8] Le Guehennec L,Goyenvalle E, Aguado E,et al.Influence of calcium chloride and aprotinin in the in vivo biological performance of a composite combing biphasic calcium phosphate granules and fibrin sealant.J Mater Sci Mater Med.2007;18(8): 1489-1495.
[9] Le Nihouannen D,Saffarzadeh A,Gauthier O,et al.Bone tissue formation in sheep muscles induced by a biphasic calcium phosphate ceramic and fibrin glue composite. J Mater Sci Mater Med.2008;19(2):667-675.
[10] Baroth S,Bourges X,Goyenvalle E,et al.Injectable biphasic calcium phosphate bioceramic: the hydros concept.Biomed Mater Eng.2009;19(1):71-76.
[11] Matsushima A,Kotobuki N,Tadokoro M, et al.In vivo osteogenic capability of human mesenchymal cell cultured on hydroxyapatite and on beta-tricalcium phosphate. Artif Organs.2009;33(6):471-481.
[12] Schneider OD,Weber F,Brunner TJ,et al.In vivo and in vitro evaluation of flexible, cottonwool-like nanocomposites as bone substitute material for complex defects. Acta Biomater. 2009;5(5):1775-1784.
[13] Tian M,Chen F,Song W,et al.In vivo study of porous strontium- doped calcium polyphosphate scaffolds for bone substitute applications. J Mater Sci Mater Med. 2009; 20(7):1505-1512.
[14] Huang Y,Jin X,Zhang X,et al.In vitro and in vivo evaluation of akermanite bioceramics for bone regeneration. Biomaterials. 2009;30(28): 5041-5048.
[15] Martinowitz U,Saltz R.Fibrin sealant.Curr Opin Hematol.1996; 3(5): 395-402.
[16] Brunk B.Fibrin glue.Dtsch Med Wochenschr.1989;114: 2028-2029.
[17] Cederholm-Williams SA.Fibrin glue.BMJ.2002;308:1570.
[18] Schlag G,Redl H.Fibrin sealant in orthopedic surgery.Clin Orthop.1988;227: 269-285.
[19] Radosevich M,Goubran HI,Burnouf T.Fibrin sealant:scientific rationale, produc -tion method, properties and current clinical use.Vox Sang.1997;72(3):133-143.
[20] Reiss RF,Oz MC.Autologous fibrin glue: production and clinical use.Transfus Med Rev.1996;10(2):85-92.
[21] Park YJ,Ku Y,Chung CP,et al.Controlled release of platelet-derived growth factor from porous poly (L-lactide) membranes for guided tissue regeneration. J Controlled Release.1998;51(2):201-211.
[22] Brown W,Chow L.A new calcium phosphate setting cement.J Dent Res.1983;62:672.
[23] Perez RA,Del Valle S,Altankov G,et al.Porous hydroxyapatite and gelatin/ hydroxyapatite microspheres obtained by calcium phosphate cement emulsion. J Biomed Mater Res B Appl Biomater.2011;97(1):156-166.
[24] Moreau JL,Weir MD,Xu HHK.Self‐setting collagen‐calcium phosphate bone cement: Mechanical and cellular properties.J Biomed Mater Res A.2009;9(2):605-613.
[25] Wang X,Ma J, Wang Y,et al. Structural characterization of phosphorylated chitosan and their applications as effective additives of calcium phosphate cements. Biomaterials.2001; 22:2247-2255.
[26] Kim NH,Yang KH,Lee HM.Effect of porcine bone morphogenetic protein on healing of bone defect in the rabbit radius.Yonsei Med J.1992;33(1):54-63.
[27] 陈克明,李旭升,刘兴炎.骨形态发生蛋白复合纤维蛋白载体修复骨缺损的实验研究[J]. 中华骨科杂志,1998,18(2):69-70.
[28] Bösch P, Lintner F, Arbes H, et al.Experimental investigations of the effect of the fibrin adhesive on the Kiel heterologous bone graft.Arch Orthop Trauma Surg. 1980;96(3):177-185.
[29] Minamide A,Kawakami M,Hashizume H.Evaluation of carriers of bone morphogenetic protein for spinal fusion.Spine.2001; 26:933-939.
[30] Coulombe J, Faure H, Robin B, et al. In vitro effects of strontium ranelate on extracellular calcium-sensing receptor.Biochem Biophys Res Commun.2004;323: 1184-1190.
[31] Sahni A, Francis CW. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation.Blood.2000;96:3772-3778.
[32] Sahni A, Odrljin T, Francis CW. Binding of basic fibroblast growth factor to fibrinogen and fibrin.J Biol Chem.1998; 273:7554-7559.
[33] Catelas I, Dwyer JF, Helgerson S. Controlled release of bioactive transforming growth factor beta-1 from fibrin gels in vitro.Tissue Eng Part C Methods.2008;14(2):119-128.
[34] Campbell PG, Durham SK, Hayes JD, et al. Insulin-like growth factor-binding protein-3 binds fibrinogen and fibrin.J Biol Chem.1999;274:30215-30221.
[35] Greco F, de Palma L, Specchia N, et al. Experimental investigation into reparative osteogenesis with fibrin adhesive. Arch Orthop Trauma Surg.1988;107(2):99-104.
[36] Oberg S, Kahnberg K.Combined use of hydroxy-apatite and Tisseel in experim -ental bone defects in the rabbit.Swedish Dent J.1993;17:147.
[37] Le Nihouannen D, Guehennec LL, Rouillon T, et al. Micro-architecture of calcium phosphate granules and fibrin glue composites for bone tissue engineering. Biomaterials. 2006;27:2716-2722.
[38] Miyazaki M, Tsumura H, Wang JC, et al. An update on bone substitutes for spinal fusion.Eur Spine J.2009;18(6):783-799.
[39] Bueno EM,Glowacki J.Cell-free and cell-based approaches for bone regeneration. Nat Rev Rheumatol.2009;5(12): 685-697.
[40] Le Guehennec L, Goyenvalle E, Aguado E, et al. Influence of calcium chloride and aprotinin in the in vivo biological performance of a composite combing biphasic calcium phosphate granules and fibrin sealant.J Mater Sci Mater Med. 2007;18(8):1489-1495.
[41] Jegoux F,Goyenvalle E,Bagot D'arc M,et al.In vivo biological performance of composites combining micro-macroporous biphasic calcium phosphate granules and fibrin sealant.Arch Orthop Trauma Surg.2005;125(3):153-159.
[42] Le Guehennec L,Goyenvalle E,Aguado E,et al. MBCP biphasic calcium phosphate granules and tissucol fibrin sealant in rabbit femoral defects: the effect of fibrin on bone ingrowth.J Mater Sci Mater Med. 2005; 16(1):29-35.
[43] Yu H,VandeVord PJ,Mao L,et al.Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization. Biomaterials. 2009;30(4):508-517.
[44] Oliveira JM,Rodrigues MT,Silva SS,et al.Novel hydroxyapatite/chitosan bilayered scaffold for osteochondral tissue-engineering applications: Scaffold design and its performance when seeded with goat bone marrow stromal cells.Biomaterials.2006; 27(36):6123-6137.
[45] Liu G,Sun J,Li Y,et al.Evaluation of partially demineralized osteoporotic cancellous bone matrix combined with human bone marrow stromal cells for tissue engineering: an in vitro and in vivo study.Calcif Tissue Int. 2008;83(3):176-185.
[46] Mastrogiacomo M,Papadimitropoulos A,Cedola A,et al.Engineering of bone using bone marrow stromal cells and a silicon-stabilized tricalcium phosphate bioceramic: evidence for a coupling between bone formation and scaffold resorption. Biomaterials. 2007;28(7):1376-1384. |